Glycotope GmbH
PrivateLast Round
VC Round
Mar 11, 2014
Total Funding Raised
$57.1M
Company Overview
Glycotope GmbH is a biotechnology company that develops tumor-specific monoclonal antibodies and glycobiology-based therapeutics for the treatment of various cancers.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Glycotope GmbH Comparables
Compare Glycotope GmbH with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Danaher | 80% | |
| Kyowa Kirin | 76% | |
| Merck & Co., Inc. | 76% | |
Glycotope GmbH Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Mar 11, 2014 | ||||
| Series A | Nov 1, 2007 |
Glycotope GmbH Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| ELSA Eckert Life Science Accelerator | Series A, VC Round, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 11, 2014
$76.2M raised from ELSA Eckert Life Science Accelerator.
Glycotope GmbH Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Glycotope GmbH's valuation, stock price, and market status.